StockData
Altria Group, Inc. logo

Altria Group, Inc.

MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/302% above fair value
$77.17−0.86 (-1.10%)

Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%

Altria Oral Tobacco Products by Quarter

Oral Tobacco Products — Reported Operating Companies Income (Reported OCI, $M) ($M)

QuarterlyAnnual

Altria Oral Tobacco Products: $434M in Q3 2026, down 5.4% from a year earlier.

Latest, Q3 2026
434
Period ended Sep 30, 2026
Change on a year earlier
-5.4%
459 in Q3 2025
History
41 quarters
Since Q4 2014
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

“|| Reported OCI | $ | 434 | $ | 459 | (5.4) | % | $ | 1,250 | $ | 1,390 | (10.1) | %”

Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOral Tobacco Products — Reported Operating Companies Income (Reported OCI, $M) ($M)Year on yearSource
Q3 2026Sep 30, 2026434-5.4%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
Q2 2026Jun 30, 2026381-23.5%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000093), filed 2026-07-30 ↗
Q1 2026Mar 31, 2026435+0.5%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000056), filed 2026-04-30 ↗
Q4 2025Dec 31, 2025438-3.3%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
Q3 2025Sep 30, 2025459-1.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
Q2 2025Jun 30, 2025498+413.4%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000093), filed 2026-07-30 ↗
Q1 2025Mar 31, 2025433-0.5%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000056), filed 2026-04-30 ↗
Q4 2024Dec 31, 2024453+11.0%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
Q3 2024Sep 30, 2024464+2.0%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-25-000128), filed 2025-10-30 ↗
Q2 2024Jun 30, 202497-78.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-25-000109), filed 2025-07-30 ↗
Q1 2024Mar 31, 2024435–Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-25-000047), filed 2025-04-29 ↗
Q4 2023Dec 31, 2023408+10.3%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-25-000006), filed 2025-01-30 ↗
Q3 2023Sep 30, 2023455+7.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-24-000100), filed 2024-10-31 ↗
Q2 2023Jun 30, 2023443+3.0%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-24-000091), filed 2024-07-31 ↗
Q4 2022Dec 31, 2022370-5.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-23-000012), filed 2023-02-01 ↗
Q3 2022Sep 30, 2022425+4.9%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-22-000100), filed 2022-10-27 ↗

Cite this data

StockData. (2026). Altria Oral Tobacco Products ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/oral-rep-oci

See every metric in the Altria KPI table. Data updated Nov 2, 2026.